hotspot -WSS

hotspot

author：leisure time 2025-09-28 23:49:27 - browse：1895

portrait of Jennifer Adair -- coverage from STAT — Jennifer Adair develops scalable, low cost gene therapies at the Fred Hutchinson Cancer Center and helped found the Global Gene Therapy Initiative. Fred Hutch News Service

BALTIMORE — Gene and cell therapies have transformed a handful of devastating disorders in the U.S. and Europe, with more treatments on the way. But those technologies have largely failed to reach most of the world.

These lags are ubiquitous in the current drug development system, where new therapies are approved in wealthy countries and then slowly leak out to low- and middle-income countries, many years later. In the case of gene therapy, that means countries most affected by a disease such as sickle cell may wait decades to access a curative therapy.

For the last few years, a handful of researchers in the U.S. and around the world have tried to find ways of ensuring global access to these technologies. In 2020, they formed the Global Gene Therapy Initiative, with an initial goal of setting up a gene therapy clinical trial for a hemoglobinopathy — such as a disease like sickle cell or beta thalassemia — or HIV in two different low- and middle-income countries by 2024.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Montana youths win climate lawsuit against state for promoting fossil fuels

Wikipedia

WSS

Judge sides with young activists in first

BioAge raises $170M for combination therapy with Zepbound

Doctors' information doesn't help them choose wisely when sick

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

What we’ve learned from the Aduhelm mess

explore

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Senators push IRS to launch nonprofit hospital probe

Malaria cases in Florida and Texas: Here’s what you need to know

Senators push IRS to launch nonprofit hospital probe

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Senators start work on Medicare physician payment reform

At least 13 dead in Texas as scorching temps continue

Judge sides with young activists in first

Walensky prepares to leave CDC — and Congress — behind

Private equity deals in Medicare Advantage declines

Wikipedia

Biden administration begins canceling student loan debt for 804,000 borrowers

YouTube cracks down on misinformation on cancer treatment

Key House Republican on health care plans exit from Congress

BioAge raises $170M for combination therapy with Zepbound

What we’ve learned from the Aduhelm mess

Illumina slashes 2023 revenue projections yet again

Wikipedia

Wikipedia

focus

knowledge